Movano Evie edges closer to launch as it hits the FDA

Movano looks for clearance for heart rate and SpO2
Wareable Movano Evie edges closer to launch as it hits the FDA photo 1
Wareable is reader-powered. If you click through using links on the site, we may earn an affiliate commission. Learn more

The Movano Evie smart ring is moving ever closer to launch, and the company has now submitted data to the FDA for certification.

The Movano Evie is a female-focussed smart ring, which looks at a wide range of health metrics – all tracked and analyzed through the lens of women’s health.

We’ve spoken to Movano and its CEO John Mastrototaro numerous times throughout the production of Evie – and he’s always been clear that the company would seek FDA approval for all its features.

> Best smart rings 2023

"We think women have been grossly underserved by the wearable market today. We feel like a lot of the products look like they were designed initially for men," he told Wareable.

“Over the next you know, three to five years, I expect six to ten different measures, that are all part of the one product, that are all FDA cleared,” he continued.

The company has submitted the heart rate and SpO2 tracking features to the FDA for initial clearance.

This is above and beyond most wearables and would be a huge statement about the basic accuracy of the Evie ring. Movano claims that its ring is accurate to within 1bpm between 40-240 bpm, and within 2% for SpO2 monitoring.

Getting FDA clearance would also pave the way for the Evie ring, or versions of it, to be used in clinical settings and for remote patient monitoring.

The company is putting a big focus on the potential for Evie to be used in professional healthcare and sees that as a huge commercial opportunity. As such, the company isn’t charging a subscription fee for its consumer services.

Oura, the major smart ring player, has a mandatory subscription of $5.99/£4.99 a month. So Evie has a huge advantage in enticing customers away from Oura.

Evie was estimated to launch this September and provided that these features don’t get stuck at the FDA, that looks odds on.

TAGGED Wearables

How we test

James Stables


James is the co-founder of Wareable, and he has been a technology journalist for 15 years.

He started his career at Future Publishing, James became the features editor of T3 Magazine and and was a regular contributor to TechRadar – before leaving Future Publishing to found Wareable in 2014.

James has been at the helm of Wareable since 2014 and has become one of the leading experts in wearable technologies globally. He has reviewed, tested, and covered pretty much every wearable on the market, and is passionate about the evolving industry, and wearables helping people achieve healthier and happier lives.

Related stories